What's breaking now, across thousands of outlets.
Jazz Pharmaceuticals will buy Actio Biosciences for $820 million upfront and up to $500 million more if certain milestones are met for its ultra-rare epilepsy drug. The deal further solidifies Jazz’s ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The UK has become the first European nation to approve a pill which helps with weight loss and treats diabetes.
As new Alzheimer's drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them and whether they truly slow the disease…
Shirley Rowe seemed to be showing the signs of age at first, but her health deteriorated rapidly following a rare diagnosis.
Samsung’s Galaxy Watch9 adds more personalized health insights, but the experience depends on setup, data collection, phone compatibility, and regional support.
Recent studies involving Estonian researchers show that mental health literacy has overlooked paying more attention to the everyday skills people need to support well-being.
The Ervebo vaccine has proved safe and effective against the more common Zaire strain of the Ebola virus, and World Health Organization experts say early data, notably from animal trials, suggest it…
